Safety and Efficacy Study of the Xoft® Axxent® eBx® IORT System®
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Invasive Ductal Carcinoma|Ductal Carcinoma in Situ
Interventions: RADIATION: Intra-operative Radiation Therapy - IORT
Sponsor: Xoft, Inc.
Collaborators: Icad, Inc.